Shares Outstanding
64.77 M
+17.10 K+0.03%
25 October 2024
Summary:
As of today, Kymera Therapeutics has 64.77 million outstanding stocks, with the most recent change of +17.10 thousand (+0.03%) on 25 October 2024. Compared to the previous year, the number of outstanding shares has increased by +9.32 million (+16.80%).KYMR Shares Outstanding Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
KYMR Shares Outstanding Performance
PeriodPeriod | Shares outstandingShares outstanding | PricePrice | Market capMarket cap |
---|---|---|---|
RecentMost recent | +0.0% | +1.5% | +1.5% |
1 y1 year | +16.8% | +144.0% | +184.8% |
3 y3 years | +26.4% | -11.8% | +11.2% |
5 y5 years | - | - | - |
KYMR Shares Outstanding High & Low
PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
---|---|---|---|---|---|
1 m | 1 month | 64.77 M | at high | 64.77 M | at low |
3 m | 3 months | 64.77 M | at high | 64.58 M | +0.3% |
6 m | 6 months | 64.77 M | at high | 61.36 M | +5.5% |
1 y | 1 year | 64.77 M | at high | 55.49 M | +16.7% |
3 y | 3 years | 64.77 M | at high | 51.39 M | +26.0% |
5 y | 5 years | 64.77 M | at high | 41.72 M | +55.2% |
alltime | all time | 64.77 M | at high | 41.72 M | +55.2% |
Kymera Therapeutics Shares Outstanding History
Date | Value |
---|---|
Oct 2024 | 64.77 M(+0.0%) |
Sept 2024 | 64.75 M(+0.3%) |
Aug 2024 | 64.58 M(+4.6%) |
Aug 2024 | 61.75 M(+0.3%) |
June 2024 | 61.57 M(+0.3%) |
Apr 2024 | 61.36 M(0.0%) |
Apr 2024 | 61.36 M(+0.0%) |
Mar 2024 | 61.35 M(+0.4%) |
Feb 2024 | 61.11 M(+2.9%) |
Jan 2024 | 59.37 M(+6.8%) |
Dec 2023 | 55.59 M(+0.2%) |
Oct 2023 | 55.49 M(+0.1%) |
Sept 2023 | 55.45 M(+0.1%) |
July 2023 | 55.41 M(+0.0%) |
June 2023 | 55.39 M(+0.1%) |
Apr 2023 | 55.31 M(+0.0%) |
Apr 2023 | 55.29 M(+0.0%) |
Mar 2023 | 55.28 M(+0.2%) |
Feb 2023 | 55.18 M(+0.3%) |
Dec 2022 | 55.04 M(+0.3%) |
Oct 2022 | 54.86 M(+0.2%) |
Sept 2022 | 54.75 M(+0.1%) |
Aug 2022 | 54.71 M(+0.0%) |
Date | Value |
---|---|
Aug 2022 | 54.69 M(+5.5%) |
Aug 2022 | 51.86 M(+0.0%) |
June 2022 | 51.85 M(+0.2%) |
Apr 2022 | 51.72 M(+0.0%) |
Apr 2022 | 51.72 M(+0.1%) |
Mar 2022 | 51.69 M(-0.0%) |
Feb 2022 | 51.70 M(+0.3%) |
Dec 2021 | 51.54 M(+0.3%) |
Oct 2021 | 51.39 M(+0.3%) |
Sept 2021 | 51.26 M(+0.4%) |
July 2021 | 51.04 M(+0.5%) |
July 2021 | 50.80 M(+12.1%) |
June 2021 | 45.33 M(+0.7%) |
Apr 2021 | 45.03 M(-0.1%) |
Apr 2021 | 45.07 M(+0.4%) |
Mar 2021 | 44.88 M(+0.2%) |
Feb 2021 | 44.81 M(+0.7%) |
Dec 2020 | 44.48 M(+0.1%) |
Oct 2020 | 44.46 M(+0.0%) |
Sept 2020 | 44.45 M(-0.2%) |
Aug 2020 | 44.53 M(+3.2%) |
Aug 2020 | 43.14 M(+3.4%) |
Aug 2020 | 41.72 M |
FAQ
- What are outstanding stocks?
- How many outstanding stocks does Kymera Therapeutics have?
- What is Kymera Therapeutics year-on-year outstanding stocks change?
- What is the all time highest number of outstanidng stocks for Kymera Therapeutics?
What are outstanding stocks?
Outstanding stocks are the shares of a company that are currently owned by shareholders, including institutional investors and company insiders
How many outstanding stocks does Kymera Therapeutics have?
As of today, Kymera Therapeutics has 64.77 M outstangding shares
What is Kymera Therapeutics year-on-year outstanding stocks change?
Over the past year, the number of outstanding stocks of KYMR has changed by +9.32 M (+16.80%)
What is the all time highest number of outstanidng stocks for Kymera Therapeutics?
Kymera Therapeutics historical maximum number of outstanding shares is 64.77 M